Financials data is unavailable for this security.
View more
Year on year BioCorRx Inc had revenues fall -58.31% from 213.84k to 89.16k, though the company grew net income from a loss of 4.37m to a smaller loss of 3.77m.
Gross margin | 49.40% |
---|---|
Net profit margin | -11,718.77% |
Operating margin | -11,214.93% |
Return on assets | -697.45% |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, BioCorRx Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 1.85m or 2,074.80% of revenues. In addition the company used 1.85m for operations while cash used for investing totalled .
Cash flow per share | -0.484 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -1.12 |
---|---|
Tangible book value per share | -1.13 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0235 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼